Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Phase I trial of PL 3994 in volunteers.

Trial Profile

Phase I trial of PL 3994 in volunteers.

Phase of Trial: Phase I

Latest Information Update: 23 Sep 2008

At a glance

  • Drugs PL 3994 (Primary)
  • Indications Chronic heart failure; Heart failure
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Palatin Technologies
  • Most Recent Events

    • 23 Sep 2008 Results reported at the 12th Annual Scientific Meeting of the Heart Failure Association of America, 2008.
    • 23 Sep 2008 Primary endpoint 'Blood pressure' has been met, according to a Palatin media release.
    • 14 Aug 2008 Results will be presented at the Annual Scientific Meeting of the Heart failure Society of America in September 2008.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top